Zetia
Zetia Price range: $ 51,00 through $ 394,00
Back to products
Zhewitra Oral Jelly
Zhewitra Oral Jelly Price range: $ 61,00 through $ 110,00

Zhewitra

Price range: $ 28,00 through $ 149,00

Zhewitra is an effective medication designed to help men manage the symptoms of erectile dysfunction and improve their sexual health. The active ingredient, Vardenafil, works by increasing blood flow to the pelvic region during physical stimulation to support a firm and lasting response. This treatment is widely recognized for its reliability, allowing for a more satisfying and predictable experience. Many individuals choose Zhewitra because it acts quickly and provides consistent results throughout the duration of its effect. By restoring natural performance, this medication helps users regain their confidence and maintain an active lifestyle.

Active substance: Vardenafil
SKU: Zhewitra Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Zhewitra belongs to a group of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It contains vardenafil as its active pharmaceutical ingredient and is designed to assist in the management of erectile dysfunction in adult males under clinical guidance.

In the United States, medications containing vardenafil are classified as prescription-only drugs. Consequently, Zhewitra must be dispensed in strict accordance with applicable federal and state regulations following a formal medical evaluation by a licensed healthcare provider.

Parameter Specification
Active ingredient Vardenafil
Primary purpose Treatment of erectile dysfunction
Route of administration Oral
Dosing (general) 10 mg taken as needed, 25 to 60 minutes prior to sexual activity
Prescription status Dispensed in accordance with applicable federal and state regulations
Storage Store at 68°F to 77°F (20°C to 25°C) away from excess moisture

Clinical and Pharmacological Profile

How the drug works

Vardenafil acts via selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During physiological sexual stimulation, nitric oxide is released from local nerve endings and endothelial cells in the corpus cavernosum of the penis. Nitric oxide activates the enzyme guanylate cyclase, leading to an increased synthesis of cGMP. Elevated intracellular cGMP levels relax smooth muscles in the arterial walls of the erectile tissue, permitting increased blood flow into the penis. PDE5 is responsible for degrading cGMP in the cavernosal tissue. By selectively inhibiting PDE5, vardenafil preserves local cGMP levels, maintaining arterial vasodilation and enhancing the natural erectile response to sexual stimulation.

What it’s used for

Zhewitra is indicated for the treatment of erectile dysfunction (ED) in adult males. Erectile dysfunction is clinically defined as the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. The therapeutic efficacy of vardenafil relies on physiological sexual arousal; the medication does not induce an erection in the absence of sensory or psychological stimulation. Any off-label applications of PDE5 inhibitors–such as off-label use for secondary Raynaud’s phenomenon or localized microvascular disorders–must be explicitly evaluated by a physician, as off-label applications fall outside the standard FDA-approved indications for vardenafil formulations.

Dosing schedule

The administration of Zhewitra should strictly follow the instructions provided by a prescribing healthcare provider. Typically, the standard starting dose of oral vardenafil is 10 mg, taken approximately 25 to 60 minutes prior to anticipated sexual intercourse. Based on individual therapeutic response and clinical tolerability, the dose may be increased to a maximum of 20 mg or decreased to 5 mg. The maximum recommended dosing frequency is once per 24-hour period. Tablets should be swallowed whole with a glass of water. Dose adjustments may be necessary for geriatric patients or individuals with mild-to-moderate hepatic impairment as determined by a licensed prescriber.

What happens in the body

Following oral administration, vardenafil is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are achieved within 30 to 120 minutes (with a median of 60 minutes) when taken in a fasted state. The absolute oral bioavailability of vardenafil is approximately 15%, primarily due to significant first-pass hepatic metabolism. Vardenafil is extensively bound to plasma proteins (approximately 95%), mainly serum albumin and alpha-1 acid glycoprotein. Hepatic metabolism occurs predominantly via the cytochrome P450 3A4 (CYP3A4) enzyme pathway, with minor contributions from CYP3A5 and CYP2C isoforms. The terminal elimination half-life ranges between 4 and 5 hours. Excretion occurs mainly as metabolic products via the feces (roughly 79%) and urine (roughly 13%).

Compatibility with other medicines

Concomitant administration of Zhewitra with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors (such as amyl nitrite) is strictly contraindicated. Co-administration can induce severe, unpredictable, and potentially life-threatening systemic hypotension. Simultaneous use with alpha-blockers (e.g., tamsulosin, doxazosin) may lead to symptomatic hypotension; such combination therapy should only be initiated if the patient is established and stable on their alpha-blocker regimen. Strong CYP3A4 inhibitors (including ketoconazole, itraconazole, and ritonavir) significantly increase systemic exposure to vardenafil, requiring dose modification or avoidance. Co-administration with Class IA or Class III antiarrhythmics should be avoided due to potential additive QT interval prolongation.

Adverse reactions

Clinical evaluations show that vardenafil is generally tolerated, though side effects may occur in some individuals. The most frequently reported adverse reactions include headache, cutaneous flushing, nasal congestion, dyspepsia (indigestion), and dizziness. Visual disturbances, such as alterations in color vision (e.g., a blue color tinge) or increased light sensitivity, occur infrequently due to minor cross-inhibition of PDE6 in retinal photoreceptors. Sudden decrease or loss of hearing and transient memory loss have been documented in rare cases. Most side effects are mild to moderate in severity and resolve spontaneously as the active drug is cleared from systemic circulation.

What to avoid while taking it

Zhewitra may be taken with or without food. However, consuming high-fat meals prior to ingestion can delay gastrointestinal absorption, resulting in a delayed peak plasma concentration and postponed therapeutic onset. Concomitant intake of substantial quantities of alcohol should be avoided; ethanol possesses inherent vasodilatory properties that can compound orthostatic hypotension, dizziness, and headache, while impairing erectile function. Additionally, grapefruit juice should be avoided because it inhibits intestinal CYP3A4 metabolism, potentially increasing circulating blood levels of vardenafil and escalating the risk of adverse reactions.

Red flags

Patients should seek immediate emergency medical care if they experience any of the following severe symptoms while taking Zhewitra:

  • Chest pain, pressure, or an irregular heartbeat during or following sexual activity.
  • A prolonged or painful erection lasting more than 4 hours (priapism), which can cause permanent penile tissue damage if left untreated.
  • Sudden partial or complete loss of vision in one or both eyes, which may indicate non-arteritic anterior ischemic optic neuropathy (NAION).
  • Sudden hearing impairment or sudden onset of severe dizziness and tinnitus.
  • Signs of a hypersensitivity reaction, such as facial swelling, hives, or difficulty breathing.

Important precautions

Caution is required when evaluating vardenafil therapy for patients with underlying cardiovascular conditions, including recent myocardial infarction, stroke, or unstable angina within the preceding six months. Patients with congenital QT prolongation or those receiving concurrent QT-prolonging medications require careful clinical evaluation. Vardenafil is not indicated for use in female patients or pediatric populations. In elderly patients (aged 65 years and older), lower initial doses are recommended due to age-related declines in hepatic clearance. Patients with severe hepatic impairment or end-stage renal disease requiring hemodialysis should avoid therapy unless explicitly managed by a specialist.

Storage and expiration

Zhewitra should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C). Keep the product in its original packaging to protect the tablets from excess moisture, heat, and direct light exposure. Do not store tablets in humid environments such as bathroom cabinets. Ensure the medication remains out of reach and out of sight of children and pets. Do not use the medication beyond the expiration date stamped on the blister packaging or outer container. Unused or expired products should be disposed of via authorized community pharmaceutical collection programs.

Frequently Asked Questions

What should be done if a scheduled dose of Zhewitra is missed?

Because Zhewitra is administered strictly on an as-needed basis prior to anticipated sexual activity, there is no fixed daily schedule for most patients. If a dose is omitted, it should simply be taken when needed prior to the next planned sexual activity. Patients must never administer a double dose or take extra medication to compensate for a missed dose.

Is it safe to drive or operate machinery after taking vardenafil?

Vardenafil can occasionally cause dizziness or visual changes, such as altered color perception or blurred vision. Patients should observe their individual response to Zhewitra before driving, operating heavy machinery, or engaging in tasks requiring uncompromised motor coordination and sharp visual acuity.

Can Zhewitra be taken concurrently with daily blood pressure medications?

Combining Zhewitra with antihypertensive medications requires clinical oversight. While co-administration with many standard blood pressure agents is medically managed, simultaneous use with alpha-blockers or nitrate formulations can cause additive hypotensive effects. Always inform your provider of all active prescription regimens.

How does food consumption impact the therapeutic onset of vardenafil?

Ingesting vardenafil with a light meal or on an empty stomach allows rapid gastrointestinal absorption. Conversely, consuming high-fat foods prior to taking the tablet delays gastric emptying, which can delay the onset of clinical effects beyond the standard 30-to-60-minute timeframe.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.

Additional information
Dosage

10 mg

,

20 mg

,

40 mg

,

60 mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

Ενεργός Ουσία